a combination of levodopa and a peripheral dopa-decarboxylase inhibitor , benzerazide ( ro 4-4602 ) , was studied over a 75-month period of observation in 132 patients with parkinson 's disease .
C0023570
levodopa
C0030567
parkinson 's disease